Can education and support ease the burden of pulmonary hypertension?

NCT ID NCT07429552

Completed Symptom relief Sponsor: Acibadem University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a dynamic blended learning module for 49 people with pulmonary hypertension, a chronic disease causing symptoms like shortness of breath and fatigue. The program included face-to-face education, regular phone follow-ups, and a video from a patient who successfully managed their symptoms. Researchers compared symptom management and quality of life between those who received the program and those who got standard care over nine months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Dynamic Blended Education Module (DBEM) including individualized education, telephone follow-up, and an educational video
What this could lead to: If successful, this approach could provide a structured way for pulmonary hypertension patients to better manage daily symptoms and improve quality of life.
What could go wrong: This is a small, completed study with only 49 participants, so results may not apply to all patients. The intervention is educational, not a medical treatment, so it cannot cure the disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LEARNING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

learning disability pulmonary hypertension

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LEARNING NURSING CARE PULMONARY HYPERTENSION

Contacts and locations

Locations

Provincial Directorate of Health

Istanbul, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.